Summit Therapeutics plc(‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results for the Fourth Period and Eleven Months Ended […]
Service revenue of $113.2 millionLoss from operations of $(4.2) millionAdjusted operating income(1) of $8.5 millionLoss before income taxes and non-controlling […]